• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON CARIBE LTD. BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON CARIBE LTD. BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING Back to Search Results
Model Number 442021
Device Problems Fluid/Blood Leak (1250); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/21/2021
Event Type  malfunction  
Event Description
It was reported while testing with bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) there was contamination of biological material.Only one bottle broke.There was no report of patient impact.The following information was provided by the initial reporter: broken bottle when taking out of the bactec fx instrument.The mentioned bactec bottle became positive.When unloading the bottle, the bottle was broken.Probably the bottle was already damaged before the bottle was loading into the instrument.The broken bottle was positive for contaminants.As for the same patient 3 other bottles were declared negative, the broken bottle was also considered as negative.No incorrect results were reported to the clinician and/or patients.
 
Manufacturer Narrative
The date received by manufacturer has been used for this field.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Manufacturer Narrative
H6: investigation: bd was unable to reproduce customer¿s experience with the bactec product for leakage/damage defect.One photo of a damage plastic bottle was received.Satisfactory results were obtained from retention samples when visually inspected.Batch history record review did not identify any evidence for which the customer submitted the complaint.A complaint history review was conducted and only the current complaint was found relating to the incident lot number and the ¿as reported¿ defect code.Complaint is confirmed based on photo received from the customer.A technical assessment was performed by the engineering department to determine if the optima filling line had mechanical issues and/or breakdowns during the manufacturing process of the aforementioned batch.Investigation revealed that preventive maintenance to the optima filling line machine was completed on time as scheduled.Upon evaluation of breakdowns / incidents reports, there were no malfunctions reported related to cap seal.Cap vision inspection system is challenged prior each lot.No trend has been identified for reported defect.Product insert warnings and precautions sections states that prior to use, each vial should be examined for evidence of contamination such as cloudiness, bulging or depresses septum, or leakage.Vials showing evidence of contamination should not be used.Also prior to use, the user should examine the vial for evidence of damage or deterioration.Vials displaying turbidity, contamination, or discoloration (darkening) should not be used.No corrective actions were required.A cross functional team continually monitors all product complaints for trends and determines if any additional actions are necessary beyond the current investigational process.
 
Event Description
It was reported while testing with bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) there was contamination of biological material.Only one bottle broke.There was no report of patient impact.The following information was provided by the initial reporter: broken bottle when taking out of the bactec fx instrument the mentioned bactec bottle became positive.When unloading the bottle, the bottle was broken.Probably the bottle was already damaged before the bottle was loading into the instrument.The broken bottle was positive for contaminants.As for the same patient 3 other bottles were declared negative, the broken bottle was also considered as negative.No incorrect results were reported to the clinician and/or patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC)
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer (Section G)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer Contact
katie swenson
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key12824572
MDR Text Key287808038
Report Number3008352382-2021-00189
Device Sequence Number1
Product Code MDB
UDI-Device Identifier00382904420215
UDI-Public00382904420215
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K123903
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/28/2022
Device Model Number442021
Device Catalogue Number442021
Device Lot Number1132357
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/27/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-